Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure;Efecto del salbutamol intravenoso vs salbutamol en micronebulizador en la hipercaliemia por insuficiencia renal crónica

Medicina Interna de Mexico

Volumn 19, Issue 4, 2003, Pages 202-205

  Balanzario, Jorge Mendoza ^a   Nuevo, José Juan Lozano ^a   Gaeta, David Enrique Hernández ^b   Rivera, Leticia Lira ^a   Ayala, Germán Vargas ^a   López, Leticia Rodríguez ^a  

^a Hospital General de Ticoman SS DF   (Mexico)

^b Hospital General Balbuena   (Spain)

Author keywords

Chronic renal failure; Hyperkalemia; Salbutamol

Indexed keywords

SALBUTAMOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; FEMALE; HEART RATE; HUMAN; HYPERKALEMIA; KIDNEY FAILURE; MALE; POTASSIUM BLOOD LEVEL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 35349018536     PISSN: 01864866     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Allon MM. Treatment and prevention of hiperkalemia in end stage renal disease. Kidney Int 1993;43:1197-209.
2. Salem MM. Extrarrenal potassium tolerance in CRF: Implications for treatment of acute hiperkalemia. Am J Kidney Disease 1991;18:421-40.
3. Clausen TE. Regulation of Na-K pump in skeletal muscule. Kidney Int 1989;35:1-13.
4. Len XR. Treatment of hiperkalemia in renal failure: salbutamol vs insulina. Nephrol Dial Transplant 1989;89:228-32.
5. Brown MR. Hipokalemic from Beta-2 receptor stimulation by circulation epinephrine. N Engl J Med 1993;339:1414-9.
6. Allon MM. Albuterol and insulin for treatment of hiperkalemia in hemodialysis patients. Kidney Int 1990;38:426-9.
7. Allon MM. Nebulized albuterol for acute hiperkalemia in hemodialysis patients. Ann Inter Med 1989;384:508-13.
8. Allon MM. Effect of bicarbonate administration of plasma potassium in dialysis patients: interaction with insulin and albuterol. Am J Kidney Dis 1996;147:713-7.
9. Montoliu JL. Treatment of hiperkalemia in renal failure with salbutamol inhalation. J Inter Med 1991;35:1-13.
10. Kurtzman NA. A patient with hiperkalemia and metabolic acidosis. Am J Kidney Dis 1990;333:333-40.
11. Montoliu JL. Potassium lowering effects of albuterol for hiperkalemia in renal failure. Arch Intern Med 1990;147:713-7.
12. Murdoch IG. Treatment of hiperkalemia with salbutamol IV. Arch Dis Child 1991;66:527-9.
13. Sally MB. Disturbances of potassium homeostasis in poisoning. Clin Toxicol 1996;33:295-310.
14. Allon MM. Effect of albuterol treatment on subsequent dialyti potassium removal. Am J Kidney Dis 1995;333:333-40.
15. Mejía-Arangure JM. El tamaño de la muestra: un enfoque práctico en la investigación pediátrica. Bol Med Hosp Infant Mex 1995;52:381-91.
16. Hung-Hsiang L, Shooh-Shan C, Shin-Chun W, et al. Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: Comparative study. Am J Kidney Disease 1994;23:266-71.